Masquelier B, Faivre R, Paty M C, Fleury H J
Laboratoire de Virologie, Université de Bordeaux II, France.
Res Virol. 1992 Jan-Feb;143(1):17-22. doi: 10.1016/s0923-2516(06)80072-5.
Anti-HIV1 trials require sensitive, reproducible and reliable parameters which measure virus load and virus production. The aim of the present study of 14 patients at different CDC stages was to compare results provided by three techniques which evaluate, respectively, cell-associated HIV1 infectivity (cell viraemia), plasma-associated HIV1 infectivity (plasma viraemia) and radiation-resistant expression ex vivo (R-HEV). For each patient, TCD4 lymphocytes were numbered and an HIV1 antigenaemia determination was carried out. We found no correlation between cellular viraemia and R-HEV; on the contrary, data concerning plasma viraemia and R-HEV were significantly correlated. While cellular viraemia and R-HEV were not correlated with TCD4 levels, plasma viraemia exhibited a significant negative correlation with TCD4 counts. Despite theoretical and practical differences, plasma viraemia and R-HEV may measure events in the viral replication cycle which bear a close resemblance; however, as designed, R-HEV seems to be far less discriminative than plasma viraemia.
